Riddhi Siddhi Gluco Biols ‘s Q1 Update: Revenue Decreases by 77.58% Year-on-Year

The comprehensive analytics outlining the performance and outlook of Riddhi Siddhi Gluco Biols Ltd‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Riddhi Siddhi Gluco Biols Ltd’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -77.58 %. However, it did see a marginal slip of -71.86 % from the previous quarter. Expenses decreased slightly by -73.05 % quarter-on-quarter, aligning with the annual decline of -77.17 %. Operating profit, while down -210 % compared to last year, faced a quarter-on-quarter increase of 92.74 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -1.85 %, but an expansion of 4.44 % sequentially. Other income rose by 26.24 % compared to the last quarter, despite an annual decline of -8.8 %. Interest expenses surged remarkably by 1.15 % from the previous quarter, yet the year-over-year decrease remains at a moderate -22.81 %. Depreciation costs fell by -17.67 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -17.98 %. Profit before tax declined annually by -7.89 % but saw an increase from the preceding quarter by 87.13 %.
Tax expenses as a percentage of profits increased slightly by 5.44 % compared to last year, with a more notable quarter-on-quarter decrease of -173.62 %. Net profit rose by 287.82 % year-on-year but experienced a 11.27 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 288.18 % but a quarterly rise of 11.26 %. In summary, Riddhi Siddhi Gluco Biols Ltd’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Riddhi Siddhi Gluco Biols Ltd’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -77.58 % year-on-year, although there was a slight dip of -71.86 % from the previous quarter. Expenses decreased by -77.17 % compared to the previous year, with a decrease of -73.05 % quarter-on-quarter. Operating Profit dropped by -210 % annually, and saw a 92.74 % increase from the last quarter.
Net Profit showed yearly increase of 287.82 %, and experienced a 11.27 % increase from the previous quarter. Earnings Per Share (EPS) rose by 288.18 % annually, however rose by 11.26 % compared to the last quarter. In essence, while Riddhi Siddhi Gluco Biols Ltd exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.